Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Natera Inc (NQ: NTRA ) 101.15 -9.22 (-8.35%) Official Closing Price Updated: 4:15 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Natera Inc < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years July 18, 2024 Via Benzinga The 3 Best Gene Editing Stocks to Buy in July 2024 July 08, 2024 Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. Via InvestorPlace $1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today July 04, 2024 Via Benzinga Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy July 03, 2024 From Natera, Inc. Via Business Wire $100 Invested In Natera 5 Years Ago Would Be Worth This Much Today June 20, 2024 Via Benzinga $1000 Invested In This Stock 5 Years Ago Would Be Worth $4,400 Today June 13, 2024 Via Benzinga Breaking Down Natera: 10 Analysts Share Their Views June 03, 2024 Via Benzinga (NTRA) - Analyzing Natera's Short Interest May 31, 2024 Via Benzinga Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... Via Talk Markets Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer June 27, 2024 From Natera, Inc. Via Business Wire Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests June 18, 2024 Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including Via MarketBeat Key Takeaways From Natera Analyst Ratings May 13, 2024 Via Benzinga Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients June 17, 2024 From Natera, Inc. Via Business Wire Amazon, Natera And A Financial Stock: CNBC's 'Final Trades' June 11, 2024 The recommendation comes after a former Amazon employee accused the Seattle-based company of selling technology to Russia. Via Benzinga Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 03, 2024 From Natera, Inc. Via Business Wire Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action May 30, 2024 On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhood Markets Inc (NASDAQ:HOOD) shares. Via Benzinga Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024 May 30, 2024 From Natera, Inc. Via Business Wire Ford Motor, Microsoft And 2 Other Stocks Insiders Are Selling May 28, 2024 Via Benzinga Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference May 23, 2024 From Natera, Inc. Via Business Wire Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting May 23, 2024 From Natera, Inc. Via Business Wire NATERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Natera, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm May 14, 2024 From Bragar Eagel & Squire Via GlobeNewswire Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday May 14, 2024 Via Benzinga Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 10, 2024 Via Benzinga Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday May 10, 2024 Via Benzinga Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise May 10, 2024 The company put up a "robust" beat and raise following an increase in test volume and sales prices in women's health and cancer detection. Via Investor's Business Daily Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket May 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 10, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 10, 2024 The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning! Via InvestorPlace US Stocks Set To End Week Strong With S&P 500 Eyeing Break Above Late-March Peak: Analyst Says He's Still A Buy In May Amid This Positive Signal May 10, 2024 U.S. stocks are on track to finish the week on a high, with the index futures pointing to a higher opening on Friday. Via Benzinga Topics Stocks Exposures US Equities Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life May 10, 2024 Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.